Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Material Event

Re: Material Event; gcduck, nice post...

in response to by
posted on Jan 07, 2008 04:17AM

I agree. The end of the litigation was a material event (or the numbers involved were so high to constitute such event), and it was reported (a bit late, perhaps due to the holidays) via the 8K. Details were not provided due to the NDA. While I was disappointed with this outcome, I do not see a violation of the letter of SEC reporting rules here (now the spirit of those rules is another matter!).

It's time to move on. Hopefully we'll get some crumbs in the next 10Q, and much more info. in the one following. In the meantime, lots of new licensee announcements, and a little revenue/earnings guidance from JT would be helpful.

Share
New Message
Please login to post a reply